Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: HPBCD

August 11, 2025 CD as API / Pharma applications

Sickle cell anemia and cyclodextrins

(The very first report on the beneficial consequence of cyclodextrin-assisted cholesterol removal from red blood cell membranes.) Sickle cell anemia

Continue reading

August 6, 2025 Drug delivery / Pharma applications / Uncategorized

Development of a nasal spray based on cyclodextrin/hydrophobically-modified hydroxypropyl-methyl cellulose for the prevention of viral respiratory infections

The work aims to develop mucoadhesive and thermo-responsive in situ gelling systems, using hydrophobically-modified hydroxypropyl-methyl cellulose (Sangelose, SG) and beta-cyclodextrin

Continue reading

July 28, 2025 Drug delivery / Pharma applications

Combining two drugs with two CDs for formulation of a dry powder for inhalation

Dry powders for inhalation are evolving to address the challenge of maximizing lung deposition, with growing interest in carrier-free formulations

Continue reading

July 21, 2025 Drug delivery / Pharma applications

Novel Ibuprofen/HP-β-CD Hydrogel for Enhanced Wound Healing Based on Oxidized Regenerated Cellulose

Preparation of the multifunctional IBU/HP-β-CD hydrogel: impeding bacterial growth, controlled drug dispensation, and enhancing wound healing A novel hydrogel system

Continue reading

July 17, 2025 Drug delivery / Pharma applications

Statins in Aqueous Cyclodextrin Ocular Preparations

Topical statin therapy holds promise for ocular diseases, such as age-related macular degeneration, but the effective delivery to the posterior

Continue reading

July 14, 2025 CD as API / Pharma applications

Novel insights from a quantitative analysis of cyclodextrin-induced ototoxicity in mice

The cochlea is vulnerable to various pathological conditions, with sensory cells typically being the primary targets of damage. However, supporting

Continue reading

July 9, 2025 CD as API / Pharma applications / Uncategorized

HPBCD and SBEBCD as therapeutic agents for the treatment of ulcerative collitis

Ulcerative colitis (UC), a major subtype of inflammatory bowel disease (IBD) alongside Crohn’s disease, is characterized by a relapsing and

Continue reading

June 24, 2025 CD as API / Pharma applications

Cholesterol Depletion by Cyclodextrins Reduces Pain Sensation

The nociceptive Transient Receptor Potential Vanilloid 1 (TRPV1) and Ankyrin 1 (TRPA1) channels are predominantly expressed on peptidergic sensory nerves,

Continue reading

June 4, 2025 Drug delivery / Pharma applications / Uncategorized

Advances in cyclodextrin-based materials: Anticancer and antimicrobial applications–A review (2021–2024)

This review explores the latest innovations in CD-based drug delivery, emphasizing their impact on both cancer treatment and antimicrobial strategies.

Continue reading

June 2, 2025 Drug delivery / Pharma applications

Does a Gut-Joint Axis exist? (Potential Role of bile acids and microbiome in Osteroarthritis treatment)

The gut-joint axis is a bidirectional communication and interaction between the gastrointestinal tract (gut) and the joints. It involves the

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 6 … 29 Next Posts»

Recent Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • 2 nd International Conference on Biomedical Science and Engineering
  • Sugammadex vs Neostigmine: Effects on Obese Patients’ Recovery
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin complexation of selected tyrosine kinase inhibitors

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (343)
  • CD derivatives (404)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (784)
  • E-ducation (63)
  • Environmental (132)
  • Events (233)
  • Food (219)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (396)
  • Other industrial use (104)
  • Pharma applications (1,172)
  • Supramolecular systems (40)
  • Uncategorized (143)

Top Posts

  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • Cyclodextrin-Amino Acid Conjugates
  • Cyclodextrin-in-Liposome for therapy: Advances and challenges
  • Pilocarpine eye drops (Vuity)
  • Lanosterol eye drops for cataract treatment
  • Characterization of the substitution pattern of 2-hydroxypropyl-β-cyclodextrin using NMR spectroscopy
  • CDs for the removal of PFAS; A review
  • Appropriate Dosing of Sugammadex in Morbidly Obese Patients
  • Cyclodextrins Meet Cosmetics, a review
  • Water-Soluble EDTA-Crosslinked Poly-β-Cyclodextrins as Ion-Complexing Drug Carriers.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers

Loading Comments...